Bentham Science Logo

Track Your Manuscript:

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 21, 4 Issues, 2021
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access


Cardiovascular & Hematological Disorders-Drug Targets , Volume 18 - Number 3

Review Article

Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases

, 18(3): 166 - 175

Vi T. Dang, Aric Huang and Geoff H. Werstuck*

DOI: 10.2174/1871529X18666180420170108

Review Article

Mutations and Common Polymorphisms in ADAMTS13 and vWF Genes Responsible for Increasing Risk of Thrombosis

, 18(3): 176 - 181

Habib Haybar, Elahe Khodadi, Maria Kavianpour and Najmaldin Saki*

DOI: 10.2174/1871529X18666180419102214

Review Article

Review Article

Review Article

Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach

, 18(3): 199 - 207

Elumalai Suguna*, Rahman Farhana, Elangovan Kanimozhi, Pindigiri Sai Kumar, Govindasamy Kumaramanickavel and Chitralekha Sai Kumar

DOI: 10.2174/1871529X18666180515130136

Research Article

Irisin in Coronary Bypass Surgery

, 18(3): 208 - 214

Suna Aydin*, Zekiye Catak, Mehmet Nesimi Eren, Askin Ender Topal and Suleyman Aydin

DOI: 10.2174/1871529X18666180511141151

Research Article

Knockout of TRPV1 Exacerbates Left Ventricular Diastolic Dysfunction Induced by A High-fat Diet in Mice

, 18(3): 215 - 223

Beihua Zhong, Jack Rubinstein, Shuangtao Ma and Donna H. Wang*

DOI: 10.2174/1871529X18666180503124538

Research Article

Adenosine and Adenosine 5’-triphosphate Catabolism in Systemic Blood as a Potential Biomarker for Doxorubicin Cardiotoxicity in an Experimental Rat Model in vivo

, 18(3): 224 - 233

Pollen K. Yeung*, Chad Purcell, Fatemeh Akhoundi and Remigius U. Agu

DOI: 10.2174/1871529X18666180406125225

Research Article

Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients

, 18(3): 234 - 238

Marjanu Hikmah Elias, Husin Azlan, Abdul Aziz Baba and Ravindran Ankathil*

DOI: 10.2174/1871529X18666180419101416

Research Article


Garry X. Shen
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook

Frontiers in Clinical Drug Research-Hematology

You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog